IMMUNOGEN, INC.

Patent Owner

Follow Compare Add to Portfolio 8Status Updates

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 103144
 
 
 
C07K PEPTIDES 6462
 
 
 
C07D HETEROCYCLIC COMPOUNDS 44107
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 9174
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 850
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 885
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 692
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 6147
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 289
 
 
 
B01D SEPARATION 1121

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2016/0114,052 POTENT CONJUGATES AND HYDROPHILIC LINKERSAug 25, 15Apr 28, 16[A61K]
2016/0115,238 CD20 Antibodies and Uses ThereofSep 16, 15Apr 28, 16[A61K, C07K]
2016/0106,863 CYTOTOXIC BENZODIAZEPINE DERIVATIVESSep 02, 15Apr 21, 16[C07D, A61K]
2016/0108,126 CD20 Antibodies and Uses ThereofSep 16, 15Apr 21, 16[A61K, C07K]
2016/0108,129 CYTOTOXIC BENZODIAZEPINE DERIVATIVESSep 09, 15Apr 21, 16[A61K, C07K]
2016/0095,938 CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTSSep 02, 15Apr 07, 16[A61K, C07K]
2016/0096,887 Folate Receptor 1 Antibodies and Immunoconjugates and Uses ThereofDec 15, 15Apr 07, 16[A61K, C07K]
2016/0096,888 Folate Receptor 1 Antibodies and Immunoconjugates and Uses ThereofDec 15, 15Apr 07, 16[A61K, C07K]
2016/0082,114 CYTOTOXIC BENZODIAZEPINE DERIVATIVESSep 02, 15Mar 24, 16[A61K, C07K]
2016/0083,471 Folate Receptor 1 Antibodies and Immunoconjugates and Uses ThereofNov 19, 15Mar 24, 16[A61K, C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9,289,509 Uses of immunoconjugates targeting CD138May 05, 10Mar 22, 16[A61K, B82Y]
9,289,512 Maytansinoid derivatives with peptide linker and conjugates thereofJun 21, 12Mar 22, 16[A61K]
9,265,841 Benzodiazepine derivativesJun 26, 14Feb 23, 16[C07D, A61K, C07K]
9,242,936 Methods for the preparation of charged crosslinkersNov 12, 14Jan 26, 16[C07D]
9,238,690 Non-antagonistic EGFR-binding molecules and immunoconjugates thereofOct 28, 11Jan 19, 16[G01N, A61K, C07K]
9,233,171 Method of treatment of tumors that are resistant to EGFR antibody therapies by EGFR antibody cytotoxic agent conjugateNov 21, 12Jan 12, 16[A61K, C07K]
9,200,073 Diagnostic assays and kits for detection of folate receptor 1Aug 30, 13Dec 01, 15[G01N, C07K]
9,173,961 CD20 antibodies and uses thereofFeb 10, 11Nov 03, 15[G01N, A61K, C07K]
9,175,086 CD20 antibodies and uses thereofFeb 10, 11Nov 03, 15[G01N, A61K, C07K]
9,169,272 Cytotoxic benzodiazepine derivativesOct 10, 14Oct 27, 15[C07D, A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0212,411 METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATESABANSep 19, 13Jul 31, 14[A61K]
2014/0093,523 Anti-Integrin Immunoconjugates, Methods and UsesABANDec 04, 13Apr 03, 14[A61K]
2013/0295,050 ANTI-IGF-I RECEPTOR ANTIBODIES, DNAS, VECTORS, HOST CELLS AND GENETIC CONSTRUCTSABANSep 14, 12Nov 07, 13[A61K]
2013/0108,620 METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATESABANNov 28, 11May 02, 13[A61K]
2012/0282,282 Methods for Decreasing Ocular Toxicity of Antibody Drug ConjugatesABANApr 04, 12Nov 08, 12[A61P, A61K]
2012/0269,827 Compositions and Methods for Treatment of Ovarian, Peritoneal, and Fallopian Tube CancerABANMar 29, 12Oct 25, 12[A61P, A61K]
2012/0259,100 PROCESS FOR MANUFACTURING CONJUGATES OF IMPROVED HOMOGENEITYABANMar 29, 12Oct 11, 12[C07K]
2012/0226,025 METHOD OF TARGETING SPECIFIC CELL POPULATIONS USING CELL-BINDING AGENT MAYTANSINOID CONJUGATES LINKED VIA A NON-CLEAVABLE LINKER, SAID CONJUGATES AND METHODS OF MAKING SAID CONJUGATESABANMay 11, 12Sep 06, 12[C07K]
2012/0226,026 POTENT CONJUGATES AND HYDROPHILIC LINKERSABANMay 17, 12Sep 06, 12[C07D, C07K]
8,137,669 Elimination of heterogeneous or mixed cell population in tumorsExpiredAug 05, 08Mar 20, 12[A61K]
8,093,358 Methods of treatment using anti-erbb antibody-maytansinoid conjugatesWithdrawnDec 03, 07Jan 10, 12[C07K]
2011/0300,162 DRUG CONJUGATE COMPOSITIONABANAug 18, 11Dec 08, 11[A61B, A61P, A61K]
2011/0280,890 PRODRUGS OF CC-1065 ANALOGSABANJul 15, 11Nov 17, 11[C07D, A61P, A61K, C07K]
8,034,904 Anti-IGF-I receptor antibodyExpiredDec 08, 03Oct 11, 11[C12P]
8,012,978 Prodrugs of CC-A1065 analogsExpiredSep 04, 08Sep 06, 11[C07F, A61K]
7,985,842 Anti-IGF-I receptor antibodyExpiredNov 24, 08Jul 26, 11[C07H, C12P, G01N, A61K, C07K]
2011/0177,064 Compositions and Methods for Treatment of Ovarian CancerABANJan 21, 11Jul 21, 11[A61P, A61K]
2011/0166,319 PROCESS FOR PREPARING PURIFIED DRUG CONJUGATESABANDec 22, 10Jul 07, 11[C07K]
2011/0097,345 NOVEL DOSING REGIMEN AND METHOD OF TREATMENTABANOct 21, 10Apr 28, 11[A61P, A61K]
7,906,545 Prodrugs of CC-1065 analogsExpiredJul 17, 09Mar 15, 11[C07D, A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.